1,341
Views
1
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

A case of polycystic ovary syndrome with inevitable miscarriage and multi-site venous thrombosis caused by hereditary protein C deficiency

, , , , , , & show all
Pages 1153-1157 | Received 03 Jul 2022, Accepted 19 Dec 2022, Published online: 12 Jan 2023

References

  • Dahlbck B. The discovery of activated protein C resistance. J Thromb Haemost. 2010;1:3–9.
  • Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia. 2008;14(6):1214–1221.
  • Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002;126(11):1337–1348.
  • Griffin JH, Evatt BL, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68(5):1370–1373.
  • Parand A, Zolghadri J, Nezam M, et al. Inherited thrombophilia and recurrent pregnancy loss. Thromb Res. 2009;123:S140.
  • Royal College of Obstetricians and Gynaecologists. Thromboembolic Disease in Pregnancy and the Puerperium: acute Management. Green-top Guideline No. 37a [S/OL.] (2015-04-30) [2017-07-15].
  • Stenflo JA. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem. 1976;251(2):355–363.
  • Negoro N, Yoshikawa J. [Protein C deficiency]. Ryoikibetsu Shokogun Shirizu 1996.
  • Koster T, Rosendaal FR, Briet E, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (leiden thrombophilia study). Blood. 1995;85(10):2756–2761.
  • Patel K, Chaney MA. Hypercoagulable states: thrombosis and embolism-ScienceDirect[J]. Complications in Anesthesia. 2nd ed. 2007:361–364.
  • Middeldorp S, Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol. 2008;143(3):321–335.
  • Wu D, Zhong Z, Chen Y, et al. Analysis of PROC and PROS1 single nucleotide polymorphisms in a thrombophilia family. Clin Respir J. 2019;13(8):530–537.
  • Mahmoodi BK, Brouwer JLP, Kate M, et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost. 2010;8(6):1193–1200.
  • Tang L, Lu X, Yu JM, et al. PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost. 2012;10:2019–26.
  • Tang L, Wang HF, Lu X, et al. Common genetic risk factors for venous thrombosis in the chinese population. Am J Hum Genet. 2013;92(2):177–187.
  • Ding Q, Shen W, Xu Y, et al. Clinical and genetic features of protein C deficiency in 23 unrelated chinese patients. Blood Cells Mol Dis. 2013;50(1):53–58.
  • Gurkan B, Sezcan M, Dila Z, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841.
  • Boden G, Rao AK. Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation. Curr Diab Rep. 2007;7(3):223–227.
  • Agrawal R, Prelevic G, Conway GS, et al. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy. Fertil Steril. 2000;73(1):56–60.
  • Vliet H, Rodrigues SP, Snieders M, et al. Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden. Thromb Res. 2008;121(6):757–761.
  • Dusse LM, Rios DRA, Pinheiro MB, et al. Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta. 2011;412(1-2):17–21.
  • Kalev M, Day T, Van de Water N, et al. Screening for a prothrombotic diathesis in patients attending family planning clinics. N Z Med J. 1999;112(1096):358–361.
  • Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, et al. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med. 2000;160(1):49–52.
  • Dinarvand P, Moser KA. Protein C deficiency. Arch Pathol Lab Med. 2019;143(10):1281–1285.
  • Menon N, Sarode R, Zia A. Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis. Blood Adv. 2018;2(2):142–145.
  • Zhao A, Wei X, et al. Chinese expert consensus on diagnosis and treatment of recurrent abortion complicated with prethrombotic state. Chin J Reprod Contraception. 2021;41(10):861–875.
  • Qi YDaH. Interpretation of ACOG guidelines for inherited thrombolic disorders in pregnancy (2018). Chin J Appl Gynecol Obstet. 2019;35:298–303.